Research

Potential Treatment for Imatinib-Resistant GIST Explored

Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially [...]

By |2019-10-31T12:01:35-04:00June 16th, 2015|Drug Treatment, News, Research|

Device Developed at MIT Helps Determine Targeted Drug Treatment

With precision medicine an accepted paradigm in cancer treatment, finding the right targeted drug treatment for each patient can prove challenging. MIT chemical engineers have designed an implantable device, which is about the size [...]

By |2019-04-08T10:26:15-04:00May 20th, 2015|News, Research|

Blueprint Medicines Presents Preclinical Data on BLU-285

Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in  treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]

By |2019-04-08T10:13:47-04:00April 24th, 2015|D842V, News, Research|

LRG Research Team Member Anette Duensing Receives 2014 GIST Award

The GIST Group Switzerland recently awarded its Science Prize to Dr. Anette Duensing, Assistant Professor of Pathology at the University of Pittsburgh Cancer Institute, and a member of the LRG’s Research Team. GIST Group [...]

By |2018-09-10T10:19:51-04:00February 4th, 2015|News, Research|

Protein Complex Believed To Be Cancer-Causing Gene

A recent study from MD Anderson provides insight into a protein complex that plays a significant role in cancer.In the study at the University of Texas MD Anderson Cancer center, similarities were drawn between bean [...]

By |2018-09-10T08:41:45-04:00January 6th, 2015|Drug Treatment, News, Research|

Strategies to rapidly identify and validate new therapies for GIST

By Dr. Anette Duensing, University of Pittsburgh Cancer Institute, and Dr. Maria Debiec-Rychter, KU Leuven, Belgium, LRG Research Team Dr. Maria Debiec-Rychter Dr. Anette Duensing Although most GISTs initially respond well [...]

By |2019-09-20T12:36:26-04:00October 24th, 2014|Drug Treatment, News, Research|

LRG patient registry: powerful tool for patients, physicians and researchers

The time it takes between the appearance of first symptoms of a rare disease and when the correct diagnosis is given, is often years if not decades instead of days or weeks like it is [...]

By |2019-09-20T12:41:08-04:00October 24th, 2014|News, Patient Registry, Research, Tissue Bank|
Go to Top